Seeking Alpha Certified
Seeking Alpha Article 11-29-2010 December Will Be Exciting for Up and Coming Corcept Pharmaceuticals: In December, the Phase 3 results for Corlux for the treatment of Cushing’s Syndrome are due out and investors have been showing an appetite for the stock as of late. This was evidenced by the unusual volume on Friday, which was a half-day for the equity markets. “Approximately 710,100 shares changed hands, a 970.6 percent increase over its 65-day average volume.” Go to Article
Seeking Alpha Article 11-23-2010 Cumberland Pharma Is Flying Under the Radar: Cumberlan (CPIX) is on deck soon for the FDA to review their drug for a potential approval with their PDUFA date on 12/10/10. They filed a supplemental drug application with the FDA in the first quarter of the year to expand the label of their liver failure injectable drug Acetadote which has already hit the market to counteract overdoses of acetaminophen. Go to Article